Abeona Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
ABEO Key Statistics
Stock Snapshot
As of today, Abeona Therapeutics(ABEO) shares are valued at $5.50. The company's market cap stands at 313.47M, with a P/E ratio of 5.98.
On 2026-05-15, Abeona Therapeutics(ABEO) stock moved within a range of $5.41 to $5.69. With shares now at $5.50, the stock is trading +1.7% above its intraday low and -3.3% below the session's peak.
Trading volume for Abeona Therapeutics(ABEO) stock has reached 1.52M, versus its average volume of 1.44M.
The stock's 52-week range extends from a low of $4.00 to a high of $7.54.
The stock's 52-week range extends from a low of $4.00 to a high of $7.54.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.